L-Propargylglycine
|
|
- CAS-Nr.
- 23235-01-0
- Englisch Name:
- L-Propargylglycine
- Synonyma:
- H-PRA-OH;L-Pra-OH;H-L-Pra-OH;H-PRA-OH HCL;L-Proparglycine;L-PROPARGYL-GLY-OH;L-PROPARGYLGLYCINE;H-PROPARGYL-GLY-OH;H-GLY(PROPARGYL)-OH;RARECHEM BK PT 0255
- CBNumber:
- CB6208192
- Summenformel:
- C5H7NO2
- Molgewicht:
- 113.11
- MOL-Datei:
- 23235-01-0.mol
|
L-Propargylglycine Eigenschaften
- Siedepunkt:
- 272.1±35.0 °C(Predicted)
- Dichte
- 1.209±0.06 g/cm3(Predicted)
- storage temp.
- Inert atmosphere,2-8°C
- pka
- 2.04±0.10(Predicted)
- Aggregatzustand
- Powder
- Farbe
- White to pale yellow
- BRN
- 2347861
- InChIKey
- DGYHPLMPMRKMPD-BYPYZUCNSA-N
- CAS Datenbank
- 23235-01-0(CAS DataBase Reference)
L-Propargylglycine Chemische Eigenschaften,Einsatz,Produktion Methoden
S-S?tze Betriebsanweisung:
S22:Staub nicht einatmen.
S24/25:Berührung mit den Augen und der Haut vermeiden.
Chemische Eigenschaften
White powder
l?uterung methode
The acid crystallises readily when ~4g in 50mL H2O are treated with absolute EtOH at 4o/3hours, and is collected, washed with cold absolute EtOH and Et2O and dried in a vacuum. Also, it recrystallises from aqueous Me2CO, RF on SiO2 TLC plates with n-BuOH/H2O/AcOH (4:1:1) is 0.26. The racemate has m 238-240o. [Leukart et al. Helv Chim Acta 59 2181 1976, Eberle & Zeller Helv Chim Acta 68 1880 1985, Jansen et al. Recl Trav Chim Pays-Bas 88 819 1969.] It is a suicide inhibitor of -cystathionase and other enzymes [Washtier & Abeles Biochemistry 16 2485 1977, Shinozuka et al. Eur J Biochem 124 377 1982].
L-Propargylglycine Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
L-Propargylglycine Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 181)Lieferanten
23235-01-0()Verwandte Suche:
- (2R)-2-Aminopent-4-ynoic acid
- (S)-2-AMINO-4-PENTYNOIC ACID
- RARECHEM BK PT 0255
- H-GLY(PROPARGYL)-OH
- H-PRA-OH
- H-PRA-OH HCL
- H-PROPARGYL-GLYCINE
- H-PROPARGYL-GLY-OH
- L-C-PROPARGYLGLYCINE
- L-PROPARGYLGLYCINE
- L-PROPARGYL-GLY-OH
- 4-Pentynoic acid, 2-amino-, (2S)-
- H-pra-OH hydrochloride
- (S)-alpha-Propargylglycine, 98% ee, 98%
- (S)-2-AMinopent-4-ynoic acid
- H-Propargyl-Gly-OH, (S)-2-AMino-4-pentynoic acid
- (S)-alpha-Propargylglycine, 98%, 98% ee
- (S)-2-Propargylglycine
- (2S)-2-Aminopent-4-ynoic acid, 2-(Prop-2-yn-1-yl)-L-glycine
- 2-Propargyl-L-glycine
- (S)-alpha-Propargylglycine
- L-Proparglycine
- L-Pra-OH
- L-Propargylglycine≥ 99% (HPLC, Chiral purity)
- (S)-α-Propargylglycine, 98% ee
- (2S)-2-Amino-4-pentynoic acid
- 2-(2-Propynyl)-L-glycine
- H-L-Pra-OH
- L-Propargylglycine, >=98%
- (2S)-2-azaniumylpent-4-ynoate
- L-Propargylglycine USP/EP/BP
- L-C-Propargylglycine >=99.0% (TLC)
- (S)-α-Propargylglycine
- L-Propargylglycine,97%
- (S)-a-Propargylglycine
- 23235-01-0
- C5H7NO2HCl
- Glycine Derivatives
- Specialty Synthesis
- Peptide Synthesis
- Unnatural Amino Acid Derivatives
- Antibiotics
- Unusual amino acids
- Amino Acids